Treatment Methods for Pain due to Bone Metastases
Journal Title: Nuclear Medicine Seminars - Year 2020, Vol 6, Issue 1
Abstract
Bone metastases are the most common cause of cancer pain, and up to two-thirds of patients with bone metastases will suffer severe pain. Given the complexity of the treatment decisions, multidisciplinary evaluation is usually necessary to decide the optimal approach to patients with bone metastases. Treatment recommendations must be individualized to each patient’s specific symptoms, clinical presentation, histologic tumor type, performance status, and patient’s goals and preferences.
Authors and Affiliations
Enver Özgencil, Ümit Akkemik
Keywords
Related Articles
- EP ID EP685343
- DOI 10.4274/nts.galenos.2020.0002
- Views 189
- Downloads 0
Guidelines for Myocardial Viability Imaging with F-18 FDG
Myocardial viability imaging with Fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT), in patients who are appropriate for coronary revascularization, in the presence of le...
The Expectations of Pediatric Urologists from Nuclear Medicine
Nuclear medicine is frequently used by pediatric urologists. Treatment planning of ureterovesical junction obstruction, vesicoureteral reflux, and similar common congenital anomalies can only be done with well-reported n...
Nuclear Medicine Procedures in Diagnosis of Infective Endocarditis
Infective endocarditis (IE) is described as infection of endocardial surfaces of heart and if available prosthesis materials. Despite all up to date developments in diagnosis and treatment of its, IE is mortal and morbid...
How Use of Radioiodine Is Changing According to Risk Groups in Well Differentiated Thyroid Cancer?
Many aspects of patient management in thyroid cancers including I-131 use are based on retrospective data or expert opinions and still debatable. With the increasing use of ultrasonography, demographics of thyroid cancer...
Procedur Guideline for Prostate Cancer Imaging: Ga68 PSMA PET/CT
This guideline, mainly for nuclear medicine physicians contains recommendations in terms of procedure, reporting and interpretation in order to standardize Gallium-68 prostate specific membrane antigen (Ga-68 PSMA) posit...